Product News
Rare Cannabinoids – Inspired by Nature & Scaled by BayMedica
In the cannabis industry, it’s hard to improve the plant. Nature has crafted a nearly perfect specimen; hearty and multi-purpose, capable of growing around the world and providing fibers, food, and medicine. When a plant can have so many purposes, it’s hard to...
The Dales Report – BayMedica Unveils Industry Leading Portfolio
Jerry P. Griffin, VP of Sales and Marketing at BayMedica, InMed’s subsidiary, is interviewed by Shadd Dales of the The Dales Report to talk about the recent B2B sales launch of rare cannabinoid #tetrahydrocannabivarin #d9 #THCV into the health and wellness sector....
What is THCV? 5 Things to Know About THCV
∆9-THCV is one the most well-researched rare cannabinoids showing effects in a myriad of conditions. THCV has been researched extensively for its appetite suppression effects that are attributed to THCV’s interaction with specific receptors involved with rewarding stimuli.
How to Future Proof Your Rare Cannabinoid Supply Chain
As everyone in the cannabis and hemp industries know, supply chain issues can be a major threat to business. The pandemic has unleashed chaos on supply chains across the globe, and the cannabis industry has not been spared. While the COVID-induced supply chain issues...
5 Things to Know About CBDV
5 Things to Know About Cannabidivarin (CBDV) 1. CBDV is a rare cannabinoid Unlike well-known cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) which are abundant in the Cannabis plant, CBDV is known as a rare, or minor, cannabinoid and is typically found...
What is cannabidivarin (CBDV)?
Cannabidivarin, also known has CBDV, is a non-intoxicating rare cannabinoid that was first isolated in 1969. CBDV may share a similar name to its well-known cousin cannabidiol, or CBD, but unlike CBD, CBDV is a minor cannabinoid and has demonstrated unique...